LEOPARD in Milan: Project Debut at the EASL Congress 2024 and ELPA Event with Patient Representatives

EASL Congress 2024: 30-minute Networking Session on LEOPARD Project

The  EASL Congress 2024 will feature a focused 30-minute networking session dedicated to presenting the general overview of the LEOPARD Horizon Europe-funded project. This significant initiative will be explored with input from key opinion leaders and patient organisations, providing a comprehensive insight into its progress and impact.

Panellists:

• Christophe Duvoux (Project Leader) - Assistance publique - Hôpitaux de Paris (*update - not attending)

• Patrizia Burra - Padua University Hospital

• Marina Berenguer - La Fe University Hospital, CIBERehd

• Marko Korenjak - European Liver Patient Association

This session offers a unique opportunity for stakeholders and participants to engage with leading experts and representatives from the patients' community, enhancing collaboration and understanding of the project's goals.

If you are attending the congress, join us on Thursday, 6 June 2024, from 16:15 to 16:45 CEST to gain valuable insights into the LEOPARD project and its contributions to liver transplant research and patient care.

For more information on the event, please visit: www.easlcongress.eu

ELPA Presents LEOPARD to Patient Representatives

The European Liver Patients’ Association (ELPA) is excited to host an event on Saturday, 8 June 2024, from 09:00 to 10:00 CEST, at the Leonardo Hotel Milan City Center, in Milan, Italy. This event will bring together 40 patient representatives from 25 countries, along with a distinguished panel of speakers. It promises to be a fantastic opportunity for the patient community to learn about the groundbreaking research and impact of the LEOPARD project while fostering open dialogue between patients and researchers.

This gathering in Milan will be an invaluable platform for patients to engage directly with researchers, ask questions, and share their experiences, ensuring that the patient's voice remains central to ongoing and future research initiatives.

These upcoming events underscore the importance of collaboration between researchers, healthcare professionals, and patients in advancing liver disease research and care. The EASL Congress networking session and the ELPA event in Milan both aim to bridge the gap between scientific research and patient experiences, fostering a more inclusive and impactful approach to tackling liver diseases and transplantation. By bringing together diverse voices and perspectives, these events will undoubtedly contribute to the ongoing efforts to improve outcomes for liver patients across Europe and beyond.